Michelle Griffin

Michelle Griffin

Director/Board Member bei ADAPTIVE BIOTECHNOLOGIES CORPORATION

Vermögen: 18 785 $ am 31.03.2024

58 Jahre
Health Technology
Commercial Services
Health Services

Profil

Michelle R.
Griffin
is an Independent Director at HTG Molecular Diagnostics, Inc. and Adaptive Biotechnologies Corp.
She was formerly Chairman at Universal Cells, Inc., Director at Sonus Pharmaceuticals, Inc., Virginia Mason Medical Center, Opexa Therapeutics, Inc., PhaseRx, Inc., and Polynoma LLC.
She was also Chief Financial Officer at Corixa Corp.
and Chief Financial Officer & Senior Vice President at Dendreon Corp.
& Emergent Product Development Seattle.
She was Chief Operating Officer & Senior Vice President at Emergent Product Development Seattle and Chief Financial Officer & Executive Vice President at OncoGenex Pharmaceuticals, Inc. She is currently an Independent Director at Acer Therapeutics, Inc. and Chinook Therapeutics, Inc. She was also a Principal at Pacific Biotechnology Consulting Group.
She received her undergraduate degree from George Mason University and her MBA from Seattle University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
01.04.2023 5 852 ( 0,00% ) 18 785 $ 31.03.2024
01.03.2023 13 ( 0,00% ) 0 $ 31.03.2024

Aktive Positionen von Michelle Griffin

UnternehmenPositionBeginn
HTG MOLECULAR DIAGNOSTICS, INC. Director/Board Member 16.08.2018
ADAPTIVE BIOTECHNOLOGIES CORPORATION Director/Board Member 01.03.2019
Alle aktiven Positionen von Michelle Griffin

Ehemalige bekannte Positionen von Michelle Griffin

UnternehmenPositionEnde
ACER THERAPEUTICS INC. Director/Board Member 17.11.2023
CHINOOK THERAPEUTICS, INC. Director/Board Member 11.08.2023
Corporate Officer/Principal 01.01.2020
Director/Board Member 01.01.2018
Director/Board Member 01.01.2018
Sehen Sie sich die Erfahrung von Michelle Griffin im Detail an

Ausbildung von Michelle Griffin

George Mason University Undergraduate Degree
Seattle University Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Michelle Griffin im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

18

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
HTG MOLECULAR DIAGNOSTICS, INC.

Commercial Services

PHASERX, INC.

Health Technology

ADAPTIVE BIOTECHNOLOGIES CORPORATION

Health Technology

Private Unternehmen13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Michelle Griffin